The Science of Changing Lives
Agentix Biosciences brings superior science technologies and unique products to the improvement and development of alternative therapies.
- Cannabinoids which may be beneficial for treating many serious diseases
- Highly respected team of doctors, researchers and business executives
- Scientific research and development committee
- Ongoing research and use of medical cannabis applications
- Product pipeline with breakthrough formulas
AGENTIX OFFERS A HIGH-CALIBRE SCIENTIFIC & RESEARCH TEAM
A Product Pipeline for Breakthrough Medicines
GSL Healthcare Inc., the company’s pharmaceutical division, has completed two significant transactions providing the company with a suite of commercialized products as well as a pipeline of therapeutic applications
GSL Healthcare acquired Applied BioPharma, LLC and its assets and has merged with Agentix Corp., a publicly listed company trading on the OTC in the United States.
Agentix has identified a targeted collection of Consumer Wellness and Pharmaceutical product opportunities, the majority of which will be designed to offer a more sophisticated and intelligent product offering in the multi-billion-dollar global Cannabinoid market. The first category shall consist of a series of health and wellness products that incorporate a proprietary and proven cellular delivery technology for the Consumer market. Further advancements of these novel biocomplexes will be used in the development and production of pharma-grade products for more specific clinical (non-prescription) applications, e.g. Arthritic Joint Pain and Onychomycosis.